Skip to content
Study details
Enrolling now

Low Dose Whole Lung Radiation Therapy for Patients With COVID-19 and Respiratory Compromise

Ohio State University Comprehensive Cancer Center
NCT IDNCT04427566ClinicalTrials.gov data as of Apr 2026
Phase

Phase 2

Target enrollment

24

Study length

about 1.4 years

Ages

18+

Locations

1 site in OH

About this study

This trial is testing whether low doses of radiation therapy to the lungs can reduce inflammation in people with COVID-19 who are having trouble breathing. The treatment uses X-ray beams from a machine to target the lungs and lessen inflammation, potentially helping patients breathe without needing a ventilator.

Based on ClinicalTrials.gov records.

What participants do

  • 1.Receive Radiation therapy
PhasePhase 2

Participation effort

Estimated from trial records. Details can vary by site.

Time + visits
Low9%
Logistics
Moderate50%

Logistics difficulty varies by site location and availability.

Trial highlights

Treatment details

Auto-extracted from trial records to preview treatments and outcomes.

Endpoints

Secondary: Change in performance status after low dose radiation to lungs, Incidence of adverse events, including severity and duration, for administration of low dose radiation to lungs

Procedures

radiation

Body systems

Infectious